Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone, muscle, red blood cells and vasculature, has executed a new 19,711 s/f lease for biotechnology laboratory space at 12 Emily St. Acceleron Pharma currently occupies a total of 75,000 s/f at 128 & 149 Sidney St., and will expand its presence to 12 Emily St. this month.
Colliers Meredith & Grew's Joe Flaherty and Tucker Hansen represented Acceleron Pharma in the transaction. The landlord, the Mass. Institute of Technology, represented itself, with John McQuaid, senior real estate officer, and Patrick Rowe, senior investment associate, handling the negotiations for the Institute. Specifics of the lease transaction were not disclosed.
12 Emily St. is a two-story, 30,000-s/f flexible office/research and development building. Located two blocks from University Park at M.I.T. and in close proximity to the M.I.T. campus, 12 Emily St. is ideally situated within the city's thriving biotechnology community.
"The addition of the 12 Emily St. facility provides additional wet laboratory and administrative office space adjacent to our existing other two facilities and will help support our rapid growth," said Nancy Sullivan, senior director of operations for Acceleron.